Position in INCY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$126,861,969
+$3,969,076 QoQ
Shares Held
1,119,107
-10.1% QoQ
Ownership
0.560%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 855 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. INCY ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in INCY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,861,969 | 1,119,107 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $122,892,893 | 1,244,233 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $96,775,548 | 1,421,080 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $82,146,792 | 1,356,677 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $121,889,555 | 1,764,725 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $111,250,266 | 1,683,060 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $128,767,003 | 2,124,167 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $116,906,541 | 2,052,072 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $123,252,814 | 1,962,937 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $107,838,912 | 1,866,694 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $115,748,646 | 1,859,416 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $131,165,063 | 1,814,931 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $125,168,760 | 1,558,376 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $95,788,069 | 1,437,396 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $104,666,224 | 1,377,731 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $138,974,437 | 1,749,867 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $123,278,162 | 1,679,539 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $113,246,407 | 1,646,502 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $141,401,413 | 1,680,749 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $146,659,029 | 1,804,590 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $163,298,426 | 1,877,425 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $168,427,621 | 1,876,840 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $177,572,026 | 1,707,916 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $139,271,377 | 1,901,835 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||